Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD

Blood

Volumn 95, Issue 4, 2000, Pages 1199-1206

  Zupo, Simona ^a   Massara, Rosanna ^b   Dono, Mariella ^b   Rossi, Edoardo ^b   Malavasi, Fabio ^b   Cosulich, M Elisabetta ^b   Ferrarini, Manlio ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CD38 ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CALCIUM MOBILIZATION; CELL DIFFERENTIATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOPHYSIOLOGY; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; PROTEIN CROSS LINKING; SIGNAL TRANSDUCTION;

EID: 0034651926     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.4.1199.004k21_1199_1206     Document Type: Article

References (48)

1. Moller G. Immunoglobulin D. Immunol Rev. 1977; 37:1.
2. Nezlin R. Internal movements in immunoglobulin molecules. Adv Immunol. 1990;48:1.
3. Terashima M, Kim KM, Adachi T, et al. The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein. Embo J. 1994;13:3782.
4. Kim KM, Adachi T, Nielsen PJ, et al. Two new proteins preferentially associated with membrane immunoglobulin D. Embo J. 1994;13:3793.
5. Adachi T, Schamel WW, Kim KM, et al. The specificity of association of the IgD molecule with the accessory proteins BAP31/BAP29 lies in the IgD transmembrane sequence. Embo J. 1996; 15: 1534.
6. Ales Martinez JE, Warner GL, Scott DW. Immunoglobulins D and M mediate signals that are qualitatively different in B cells with an immature phenotype. Proc Natl Acad Sci U S A. 1988;85: 6919.
7. Tisch R, Roifman CM, Hozumi N. Functional differences between immunoglobulins M and D expressed on the surface of an immature B-cell line. Proc Natl Acad Sci U S A. 1988;85:6914.
8. Kim KM. Reth M. Signaling difference between class IgM and IgD antigen receptors. Ann N Y Acad Sci. 1995;766:81.
9. Carsetti R, Kohler G, Lamers MC. A role for immunoglobulin D: interference with tolerance induction. Eur J Immunol. 1993;23:168.
10. Carsetti R, Kohler G, Lamers MC. Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med. 1995;181:2129.
11. Norvell A, Monroe JG. Acquisition of surface IgD fails to protect from tolerance induction: both surface IgM and surface IgD-mediated signals induce apoptosis of immature murine B lymphocytes. J Immunol. 1996;156:1328.
12. Brink R, Goodnow CC, Crosbie J, et al. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J Exp Med. 1992;176:991.
13. Cambier JC, Monroe JG. B cell activation, V: differentiation signaling of B cell membrane depolarization, increased I-A expression, G0 to G1 transition, and thymidine uptake by anti-IgM and anti-IgD antibodies. J Immunol. 1984;133:576.
14. Sieckmann DG. The use of antiimmunoglobulins to induce a signal for cell division in B lymphocytes via their membrane IgM and IgD. Immunol Rev. 1980;52:181.
15. Zupo S, Isnardi L, Megna M, et al. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to antiIgM antibodies and propensity to apoptosis. Blood. 1996;88:1365.
16. Dighiero G, Kipps T, Schroeder HW, et al. What is the CLL B-lymphocyte? Leuk Lymphoma. 1996; 22(suppl 2):13.
17. Caligaris Cappio F. B-chronic lymphocytic leukemia: a malignancy of antiself B cells. Blood. 1996; 87:2615.
18. Zupo S, Rugari E, Dono M, Taborelli G, Malavasi F, Ferrarini M. CD38 signaling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cells. Eur J Immunol. 1994; 24: 1218.
19. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 1994;84:1415.
20. Gottardi D, De Leo AM, Alfarano A, et al. Fludarabine ability to down-regulate Bcl-2 gene product in CD5+ leukaemic B cells: in vitro/in vivo correlations. Br J Haematol. 1997;99:147.
21. Ambrosio DD, Hippen KL, Minskoff SA, et al. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1 [see comments]. Science. 1995; 268:293.
22. Yellen Shaw A, Monroe JG. Differential responsiveness of immature- and mature-stage murine B cells to antiIgM reflects both FcR-dependent and -independent mechanisms. Cell Immunol. 1992;145:339.
23. Cutrona G, Ulivi M, Fais F, Roncella S, Ferrarini M. Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts. J Exp Med. 1995;181:699.
24. Arpin C, Banchereau J, Liu YJ. Memory B cells are biased towards terminal differentiation: a strategy that may prevent repertoire freezing. J Exp Med. 1997;186:931.
25. Wijdenes J, Vooijs WC, Clement C, et al. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br J Haematol. 1996;94: 318.
26. Kim KM, Yoshimura T, Watanabe H, et al. Growth regulation of a human mature B cell line, B104, by antiIgM and antiIgD antibodies. J Immunol. 1991;146:819.
27. Mongini PK, Blessinger C, Posnett DN, Rudich SM. Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations. J Immunol. 1989;143:1565.
28. Cantwell M, Hua T, Pappas J, Kipps TJ. Acquired CD40-ligand deficiency in chronic lymphocytic leukemia. Nat Med. 1997;3:984.
29. Lund FE, Solvason NW, Cooke MP, et al. Signaling through murine CD38 is impaired in antigen receptor-unresponsive B cells. Eur J Immunol. 1995;25:1338.
30. Lund FE, Yu N, Kim KM, Reth M, Howard MC. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression. J Immunol. 1996;157:1455.
31. Lund FE, Cockayne DA, Randall TD, Solvason N, Schuber F, Howard MC. CD38: a new paradigm in lymphocyte activation and signal transduction. Immunol Rev. 198;161:79.
32. Malavasi F, Funaro A, Roggero S, Horenstein A, Calosso L, Mehta K. Human CD38: a glycoprotein in search of a function. Immunol Today. 1994; 5:95.
33. Ferrero E, Malavasi F. The metamorphosis of a molecule: from soluble enzyme to the leukocyte receptor CD38. J Leukoc Biol. 1999;65:151.
34. Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan IC. Mechanism of antigen-driven selection in germinal centres. Nature. 1989;342:929.
35. Lebecque S, de Bouteiller O, Arpin C, Banchereau J, Liu YJ. Germinal center founder cells display propensity for apoptosis before onset of somatic mutation. J Exp Med. 1997;185: 563.
36. Pascual V, Liu YJ, Magalski A, de Bouteiller O, Banchereau J, Capra JD. Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med. 1994;180:329.
37. Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102:1515.
38. Damle RN, Wasil T, Fais F, et al. Immunoglobulin V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840.
39. Hueber AO, Zornig M, Lyon D, Suda T, Nagata S, Evan GI. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis [see comments]. Science. 1997;278:1305.
40. Graves JD, Draves KE, Craxton A, Saklatvala J, Krebs EG, Clark EA. Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes. Proc Natl Acad Sci U S A. 1996;93:13,814.
41. Benschop RJ, Cambier JC. B cell development: signal transduction by antigen receptors and their surrogates. Curr Opin Immunol. 1999;11:143.
42. Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992;69:119.
43. Boise LH, Gonzalez Garcia M, Postema CE, et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 1993;74:597.
44. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74:609.
45. Takayama S, Sato T, Krajewski S, et al. Cloning and functional analysis of BAG-1 : a novel Bcl-2-binding protein with anticell death activity. Cell. 1995;80:279.
46. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell. 1995;80:285.
47. Roes J, Rajewsky K. Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells. J Exp Med. 1993;177:45.
48. Nitschke L, Kosco MH, Kohler G, Lamers MC. Immunoglobulin D-deficient mice can mount normal immune responses to thymus-independent and -dependent antigens. Proc Natl Acad Sci U S A. 1993;90:1887.